Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Ménoret, Antoine ^a   Kumar, Sanjeev ^a   Vella, Anthony T ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME B5; CYTOKERATIN 17; STAPHYLOCOCCUS ENTEROTOXIN A;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FUNCTIONAL PROTEOMICS; LUNG LAVAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TOXIC INHALATION; VALIDATION PROCESS;

ACUTE LUNG INJURY; ADMINISTRATION, INHALATION; ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOCHROMES B5; DISEASE MODELS, ANIMAL; ENTEROTOXINS; INFLAMMATION; KERATIN-17; MICE; PROTEOMICS;

MUS; STAPHYLOCOCCUS AUREUS;

EID: 84863698432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040184     Document Type: Article

References (52)

1. Kuebler WM, (2011) Biomarkers of acute respiratory distress syndrome: Do good things lie nearby? Crit Care Med 39: 207-209.
2. Gaggar A, Olman MA, (2006) Biologic markers of mortality in acute lung injury. Clin Chim Acta 372: 24-32.
3. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, et al. (2011) An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44: 725-738.
4. Thomas D, Chou S, Dauwalder O, Lina G, (2007) Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy 93: 24-41.
5. Iscimen R, Cartin-Ceba R, Yilmaz M, Khan H, Hubmayr RD, et al. (2008) Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med 36: 1518-1522.
6. Johnson ER, Matthay MA, (2010) Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv 23: 243-252.
7. Matute-Bello G, Frevert CW, Martin TR, (2008) Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: L379-399.
8. Bachert C, Gevaert P, Zhang N, van Zele T, Perez-Novo C, (2007) Role of staphylococcal superantigens in airway disease. Chem Immunol Allergy 93: 214-236.
9. Tripathi A, Kern R, Conley DB, Seiberling K, Klemens JC, et al. (2005) Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses. Am J Rhinol 19: 327-333.
10. Kim ST, Chung SW, Jung JH, Ha JS, Kang IG, (2011) Association of T cells and eosinophils with Staphylococcus aureus exotoxin A and toxic shock syndrome toxin 1 in nasal polyps. Am J Rhinol Allergy 25: 19-24.
11. Muralimohan G, Rossi RJ, Guernsey LA, Thrall RS, Vella AT, (2008) Inhalation of Staphylococcus aureus enterotoxin A induces IFN-gamma and CD8 T cell-dependent airway and interstitial lung pathology in mice. J Immunol 181: 3698-3705.
12. Nakanishi M, Menoret A, Belinsky GS, Giardina C, Godman CA, et al. (2007) Utilizing endoscopic technology to reveal real-time proteomic alterations in response to chemoprevention. Proteomics Clin Appl 1: 1660-1666.
13. Beckhove P, Warta R, Lemke B, Stoycheva D, Momburg F, et al. (2010) Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation. J Clin Invest 120: 2230-2242.
14. Lee HJ, Kang MJ, Lee EY, Cho SY, Kim H, et al. (2008) Application of a peptide-based PF2D platform for quantitative proteomics in disease biomarker discovery. Proteomics 8: 3371-3381.
15. Menoret A, McAleer JP, Ngoi SM, Ray S, Eddy NA, et al. (2009) The oxazolidinone derivative locostatin induces cytokine appeasement. J Immunol 183: 7489-7496.
16. Han SG, Andrews R, Gairola CG, Bhalla DK, (2008) Acute pulmonary effects of combined exposure to carbon nanotubes and ozone in mice. Inhal Toxicol 20: 391-398.
17. Mantecca P, Farina F, Moschini E, Gallinotti D, Gualtieri M, et al. (2010) Comparative acute lung inflammation induced by atmospheric PM and size-fractionated tire particles. Toxicol Lett 198: 244-254.
18. Dobryszycka W, (1997) Biological functions of haptoglobin-new pieces to an old puzzle. Eur J Clin Chem Clin Biochem 35: 647-654.
19. Engstrom G, Segelstorm N, Ekberg-Aronsson M, Nilsson PM, Lindgarde F, et al. (2009) Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study. Thorax 64: 211-215.
20. Lombard N, Swart AC, van der Merwe MJ, Swart P, (2002) Sheep adrenal cytochrome b5: active as a monomer or a tetramer in vivo? Endocr Res 28: 485-492.
21. LeClaire RD, Hunt RE, Bavari S, Estep JE, Nelson GO, et al. (1996) Potentiation of inhaled staphylococcal enterotoxin B-induced toxicity by lipopolysaccharide in mice. Toxicol Pathol 24: 619-626.
22. Rieder SA, Nagarkatti P, Nagarkatti M, (2011) CD1d-Independent Activation of Invariant Natural Killer T Cells by Staphylococcal Enterotoxin B through Major Histocompatibility Complex Class II/T Cell Receptor Interaction Results in Acute Lung Injury. Infect Immun 79: 3141-3148.
23. Miyakawa H, Sato K, Shinbori T, Okamoto T, Gushima Y, et al. (2002) Effects of inducible nitric oxide synthase and xanthine oxidase inhibitors on SEB-induced interstitial pneumonia in mice. Eur Respir J 19: 447-457.
24. Levitt JE, Gould MK, Ware LB, Matthay MA, (2009) The pathogenetic and prognostic value of biologic markers in acute lung injury. J Intensive Care Med 24: 151-167.
25. Calfee CS, Eisner MD, Ware LB, Thompson BT, Parsons PE, et al. (2007) Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 35: 2243-2250.
26. Bajaj MS, Tricomi SM, (1999) Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome. Intensive Care Med 25: 1259-1266.
27. Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA, (2004) Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 170: 766-772.
28. Ishizaka A, Matsuda T, Albertine KH, Koh H, Tasaka S, et al. (2004) Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 286: L1088-1094.
29. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, et al. (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63: 1083-1089.
30. Cheng IW, Ware LB, Greene KE, Nuckton TJ, Eisner MD, et al. (2003) Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 31: 20-27.
31. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K, (2003) Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 58: 983-988.
32. Kropski JA, Fremont RD, Calfee CS, Ware LB, (2009) Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 135: 1440-1447.
33. Tenholder MF, Rajagopal KR, Phillips YY, Dillard TA, Bennett LL, et al. (1991) Urinary desmosine excretion as a marker of lung injury in the adult respiratory distress syndrome. Chest 100: 1385-1390.
34. Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, et al. (2005) Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 33: 1-6; discussion 230-232.
35. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, et al. (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107: 1062-1073.
36. Calfee CS, Ware LB, Glidden DV, Eisner MD, Parsons PE, et al. (2011) Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 39: 711-717.
37. Schenkman JB, Jansson I, (2003) The many roles of cytochrome b5. Pharmacol Ther 97: 139-152.
38. Giordano SJ, Steggles AW, (1993) Differential expression of the mRNAs for the soluble and membrane-bound forms of rabbit cytochrome b5. Biochim Biophys Acta 1172: 95-100.
39. Lederer F, Ghrir R, Guiard B, Cortial S, Ito A, (1983) Two homologous cytochromes b5 in a single cell. Eur J Biochem 132: 95-102.
40. Vergeres G, Waskell L, (1995) Cytochrome b5, its functions, structure and membrane topology. Biochimie 77: 604-620.
41. Durr UH, Waskell L, Ramamoorthy A, (2007) The cytochromes P450 and b5 and their reductases-promising targets for structural studies by advanced solid-state NMR spectroscopy. Biochim Biophys Acta 1768: 3235-3259.
42. Finn RD, McLaughlin LA, Ronseaux S, Rosewell I, Houston JB, et al. (2008) Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. J Biol Chem 283: 31385-31393.
43. Theken KN, Deng Y, Kannon MA, Miller TM, Poloyac SM, et al. (2011) Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism. Drug Metab Dispos 39: 22-29.
44. Tesfaigzi Y, Kluger M, Kozak W, (2001) Clinical and cellular effects of cytochrome P-450 modulators. Respir Physiol 128: 79-87.
45. Hung CH, Chen LC, Zhang Z, Chowdhury B, Lee WL, et al. (2004) Regulation of TH2 responses by the pulmonary Clara cell secretory 10-kd protein. J Allergy Clin Immunol 114: 664-670.
46. Chroneos ZC, Sever-Chroneos Z, Shepherd VL, (2010) Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem 25: 13-26.
47. Madan T, Reid KB, Clark H, Singh M, Nayak A, et al. (2010) Susceptibility of mice genetically deficient in SP-A or SP-D gene to invasive pulmonary aspergillosis. Mol Immunol 47: 1923-1930.
48. Henderson NC, Sethi T, (2009) The regulation of inflammation by galectin-3. Immunol Rev 230: 160-171.
49. Sato S, St-Pierre C, Bhaumik P, Nieminen J, (2009) Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230: 172-187.
50. Depianto D, Kerns ML, Dlugosz AA, Coulombe PA, (2010) Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet 42: 910-914.
51. Barre O, Solioz M, (2006) Improved protocol for chromatofocusing on the ProteomeLab PF2D. Proteomics 6: 5096-5098.
52. Keller A, Nesvizhskii AI, Kolker E, Aebersold R, (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392.